ID   SPTN2_RAT               Reviewed;        2388 AA.
AC   Q9QWN8; O88197; Q9ES68;
DT   16-NOV-2001, integrated into UniProtKB/Swiss-Prot.
DT   16-NOV-2001, sequence version 2.
DT   24-JAN-2024, entry version 157.
DE   RecName: Full=Spectrin beta chain, non-erythrocytic 2;
DE   AltName: Full=Beta SpIII sigma 1;
DE   AltName: Full=Beta-III spectrin;
DE   AltName: Full=Glutamate transporter EAAT4-associated protein 41;
DE   AltName: Full=SPNB-3;
DE   AltName: Full=Spectrin-like protein GTRAP41;
GN   Name=Sptbn2; Synonyms=Spnb3;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RX   PubMed=9675416; DOI=10.1016/s0169-328x(98)00068-0;
RA   Ohara O., Ohara R., Yamakawa H., Nakajima D., Nakayama M.;
RT   "Characterization of a new beta-spectrin gene which is predominantly
RT   expressed in brain.";
RL   Brain Res. Mol. Brain Res. 57:181-192(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RX   PubMed=9704016; DOI=10.1006/bbrc.1998.9067;
RA   Sakaguchi G., Orita S., Naito A., Maeda M., Igarashi H., Sasaki T.,
RA   Takai Y.;
RT   "A novel brain-specific isoform of beta spectrin: isolation and its
RT   interaction with Munc13.";
RL   Biochem. Biophys. Res. Commun. 248:846-851(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=11242047; DOI=10.1038/35065091;
RA   Jackson M., Song W., Liu M.-Y., Jin L., Dykes-Hoberg M., Lin C.-L.G.,
RA   Bowers W.J., Federoff H.J., Sternweis P.C., Rothstein J.D.;
RT   "Modulation of the neuronal glutamate transporter EAAT4 by two interacting
RT   proteins.";
RL   Nature 410:89-93(2001).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1574, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=16641100; DOI=10.1073/pnas.0600895103;
RA   Hoffert J.D., Pisitkun T., Wang G., Shen R.-F., Knepper M.A.;
RT   "Quantitative phosphoproteomics of vasopressin-sensitive renal cells:
RT   regulation of aquaporin-2 phosphorylation at two sites.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:7159-7164(2006).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-6; SER-31; SER-1073; SER-2169
RP   AND SER-2199, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Probably plays an important role in neuronal membrane
CC       skeleton.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton. Cytoplasm, cell cortex.
CC   -!- TISSUE SPECIFICITY: Abundantly transcribed in the brain. Neurons are
CC       the predominant cell-type to express the gene. Found abundantly in
CC       Purkinje cells.
CC   -!- SIMILARITY: Belongs to the spectrin family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB008551; BAA32699.1; -; mRNA.
DR   EMBL; AB001347; BAA32473.1; -; mRNA.
DR   EMBL; AF225960; AAG28596.1; -; mRNA.
DR   PIR; JE0271; JE0271.
DR   AlphaFoldDB; Q9QWN8; -.
DR   BMRB; Q9QWN8; -.
DR   SMR; Q9QWN8; -.
DR   BioGRID; 247889; 6.
DR   IntAct; Q9QWN8; 2.
DR   MINT; Q9QWN8; -.
DR   STRING; 10116.ENSRNOP00000070189; -.
DR   GlyGen; Q9QWN8; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q9QWN8; -.
DR   PhosphoSitePlus; Q9QWN8; -.
DR   jPOST; Q9QWN8; -.
DR   PaxDb; 10116-ENSRNOP00000026573; -.
DR   UCSC; RGD:3751; rat.
DR   AGR; RGD:3751; -.
DR   RGD; 3751; Sptbn2.
DR   eggNOG; KOG0517; Eukaryota.
DR   InParanoid; Q9QWN8; -.
DR   PhylomeDB; Q9QWN8; -.
DR   Reactome; R-RNO-2132295; MHC class II antigen presentation.
DR   Reactome; R-RNO-375165; NCAM signaling for neurite out-growth.
DR   Reactome; R-RNO-445095; Interaction between L1 and Ankyrins.
DR   Reactome; R-RNO-5673001; RAF/MAP kinase cascade.
DR   Reactome; R-RNO-6807878; COPI-mediated anterograde transport.
DR   PRO; PR:Q9QWN8; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0016324; C:apical plasma membrane; ISO:RGD.
DR   GO; GO:0030054; C:cell junction; IBA:GO_Central.
DR   GO; GO:0042995; C:cell projection; IBA:GO_Central.
DR   GO; GO:0030864; C:cortical actin cytoskeleton; IBA:GO_Central.
DR   GO; GO:0005737; C:cytoplasm; TAS:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005768; C:endosome; IDA:RGD.
DR   GO; GO:0098978; C:glutamatergic synapse; ISO:RGD.
DR   GO; GO:0000139; C:Golgi membrane; IDA:RGD.
DR   GO; GO:0043025; C:neuronal cell body; ISO:RGD.
DR   GO; GO:0016363; C:nuclear matrix; TAS:UniProtKB.
DR   GO; GO:0098688; C:parallel fiber to Purkinje cell synapse; ISO:RGD.
DR   GO; GO:0033010; C:paranodal junction; ISO:RGD.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:RGD.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0099189; C:postsynaptic spectrin-associated cytoskeleton; ISO:RGD.
DR   GO; GO:0098793; C:presynapse; ISO:RGD.
DR   GO; GO:0008091; C:spectrin; ISO:RGD.
DR   GO; GO:0008021; C:synaptic vesicle; IDA:RGD.
DR   GO; GO:0051015; F:actin filament binding; IBA:GO_Central.
DR   GO; GO:0005543; F:phospholipid binding; IEA:InterPro.
DR   GO; GO:0005200; F:structural constituent of cytoskeleton; TAS:UniProtKB.
DR   GO; GO:0099186; F:structural constituent of postsynapse; ISO:RGD.
DR   GO; GO:0098918; F:structural constituent of synapse; IBA:GO_Central.
DR   GO; GO:0030036; P:actin cytoskeleton organization; IBA:GO_Central.
DR   GO; GO:0051693; P:actin filament capping; IEA:UniProtKB-KW.
DR   GO; GO:0030534; P:adult behavior; ISO:RGD.
DR   GO; GO:0071361; P:cellular response to ethanol; IEP:RGD.
DR   GO; GO:0021692; P:cerebellar Purkinje cell layer morphogenesis; ISO:RGD.
DR   GO; GO:0035264; P:multicellular organism growth; ISO:RGD.
DR   GO; GO:0099173; P:postsynapse organization; ISO:RGD.
DR   GO; GO:0017158; P:regulation of calcium ion-dependent exocytosis; TAS:UniProtKB.
DR   GO; GO:0099150; P:regulation of postsynaptic specialization assembly; ISO:RGD.
DR   GO; GO:0007416; P:synapse assembly; ISO:RGD.
DR   GO; GO:0016081; P:synaptic vesicle docking; TAS:UniProtKB.
DR   GO; GO:0016079; P:synaptic vesicle exocytosis; IPI:UniProtKB.
DR   GO; GO:0016192; P:vesicle-mediated transport; ISO:RGD.
DR   CDD; cd21246; CH_SPTB-like_rpt1; 1.
DR   CDD; cd21321; CH_SPTBN2_rpt2; 1.
DR   CDD; cd10571; PH_beta_spectrin; 1.
DR   CDD; cd00176; SPEC; 8.
DR   Gene3D; 1.20.58.60; -; 13.
DR   Gene3D; 1.10.418.10; Calponin-like domain; 2.
DR   Gene3D; 2.30.29.30; Pleckstrin-homology domain (PH domain)/Phosphotyrosine-binding domain (PTB); 1.
DR   InterPro; IPR001589; Actinin_actin-bd_CS.
DR   InterPro; IPR001715; CH_dom.
DR   InterPro; IPR036872; CH_dom_sf.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR041681; PH_9.
DR   InterPro; IPR001605; PH_dom-spectrin-type.
DR   InterPro; IPR001849; PH_domain.
DR   InterPro; IPR018159; Spectrin/alpha-actinin.
DR   InterPro; IPR016343; Spectrin_bsu.
DR   InterPro; IPR002017; Spectrin_repeat.
DR   PANTHER; PTHR11915:SF325; SPECTRIN BETA CHAIN, NON-ERYTHROCYTIC 2; 1.
DR   PANTHER; PTHR11915; SPECTRIN/FILAMIN RELATED CYTOSKELETAL PROTEIN; 1.
DR   Pfam; PF00307; CH; 2.
DR   Pfam; PF15410; PH_9; 1.
DR   Pfam; PF00435; Spectrin; 17.
DR   PIRSF; PIRSF002297; Spectrin_beta_subunit; 1.
DR   PRINTS; PR00683; SPECTRINPH.
DR   SMART; SM00033; CH; 2.
DR   SMART; SM00233; PH; 1.
DR   SMART; SM00150; SPEC; 17.
DR   SUPFAM; SSF47576; Calponin-homology domain, CH-domain; 1.
DR   SUPFAM; SSF50729; PH domain-like; 1.
DR   SUPFAM; SSF46966; Spectrin repeat; 13.
DR   PROSITE; PS00019; ACTININ_1; 1.
DR   PROSITE; PS00020; ACTININ_2; 1.
DR   PROSITE; PS50021; CH; 2.
DR   PROSITE; PS50003; PH_DOMAIN; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Actin capping; Actin-binding; Cytoplasm; Cytoskeleton;
KW   Phosphoprotein; Reference proteome; Repeat.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:O15020"
FT   CHAIN           2..2388
FT                   /note="Spectrin beta chain, non-erythrocytic 2"
FT                   /id="PRO_0000073464"
FT   DOMAIN          57..161
FT                   /note="Calponin-homology (CH) 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00044"
FT   DOMAIN          176..281
FT                   /note="Calponin-homology (CH) 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00044"
FT   REPEAT          306..414
FT                   /note="Spectrin 1"
FT                   /evidence="ECO:0000255"
FT   REPEAT          427..527
FT                   /note="Spectrin 2"
FT                   /evidence="ECO:0000255"
FT   REPEAT          532..639
FT                   /note="Spectrin 3"
FT                   /evidence="ECO:0000255"
FT   REPEAT          642..744
FT                   /note="Spectrin 4"
FT                   /evidence="ECO:0000255"
FT   REPEAT          749..849
FT                   /note="Spectrin 5"
FT                   /evidence="ECO:0000255"
FT   REPEAT          856..954
FT                   /note="Spectrin 6"
FT                   /evidence="ECO:0000255"
FT   REPEAT          960..1063
FT                   /note="Spectrin 7"
FT                   /evidence="ECO:0000255"
FT   REPEAT          1066..1169
FT                   /note="Spectrin 8"
FT                   /evidence="ECO:0000255"
FT   REPEAT          1174..1266
FT                   /note="Spectrin 9"
FT                   /evidence="ECO:0000255"
FT   REPEAT          1279..1379
FT                   /note="Spectrin 10"
FT                   /evidence="ECO:0000255"
FT   REPEAT          1384..1485
FT                   /note="Spectrin 11"
FT                   /evidence="ECO:0000255"
FT   REPEAT          1489..1586
FT                   /note="Spectrin 12"
FT                   /evidence="ECO:0000255"
FT   REPEAT          1589..1692
FT                   /note="Spectrin 13"
FT                   /evidence="ECO:0000255"
FT   REPEAT          1696..1797
FT                   /note="Spectrin 14"
FT                   /evidence="ECO:0000255"
FT   REPEAT          1801..1904
FT                   /note="Spectrin 15"
FT                   /evidence="ECO:0000255"
FT   REPEAT          1910..2010
FT                   /note="Spectrin 16"
FT                   /evidence="ECO:0000255"
FT   REPEAT          2017..2078
FT                   /note="Spectrin 17"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          2218..2328
FT                   /note="PH"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00145"
FT   REGION          2..278
FT                   /note="Actin-binding"
FT   REGION          2080..2112
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          2124..2207
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          2333..2388
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        2080..2099
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        2124..2169
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        2367..2388
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         2
FT                   /note="N-acetylserine"
FT                   /evidence="ECO:0000250|UniProtKB:O15020"
FT   MOD_RES         6
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         31
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         959
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O15020"
FT   MOD_RES         1073
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         1574
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:16641100"
FT   MOD_RES         2169
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         2199
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         2354
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:O15020"
FT   MOD_RES         2359
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O15020"
FT   CONFLICT        326..328
FT                   /note="VTL -> GTF (in Ref. 3; AAG28596)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        543
FT                   /note="L -> F (in Ref. 2; BAA32473)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        608
FT                   /note="D -> G (in Ref. 3; AAG28596)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        887
FT                   /note="L -> P (in Ref. 3; AAG28596)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        908
FT                   /note="V -> I (in Ref. 3; AAG28596)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        948
FT                   /note="D -> G (in Ref. 3; AAG28596)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1156..1157
FT                   /note="EL -> GA (in Ref. 2; BAA32473)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1194
FT                   /note="F -> V (in Ref. 2; BAA32473 and 3; AAG28596)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1555
FT                   /note="G -> R (in Ref. 3; AAG28596)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1769
FT                   /note="R -> W (in Ref. 3; AAG28596)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   2388 AA;  271064 MW;  3EC8966AF0665F19 CRC64;
     MSSTLSPTDF DSLEIQGQYS DINNRWDLPD SDWDNDSSSA RLFERSRIKA LADEREAVQK
     KTFTKWVNSH LARVTCRVGD LYSDLRDGRN LLRLLEVLSG ETLPKPTKGR MRIHCLENVD
     KALQFLKEQK VHLENMGSHD IVDGNHRLTL GLVWTIILRF QIQDISVETE DNKEKKSAKD
     ALLLWCQMKT AGYPNVNVHN FTTSWRDGLA FNAIVHKHRP DLLDFESLKK CNAHYNLQNA
     FNLAEKELGL TKLLDPEDVN VDQPDEKSII TYVATYYHYF SKMKALAVEG KRIGKVLDHA
     MEAEHLVEKY ESLASELLQW IEQTIVTLND RQLANSLSGV QNQLQSFNSY RTVEKPPKFT
     EKGNLEVLLF TIQSKLRANN QKVYTPREGR LISDINKAWE RLEKAEHERE LALRTELIRQ
     EKLEQLAARF DRKAAMRETW LSENQRLVSQ DNFGLELAAV EAAVRKHEAI ETDIVAYSGR
     VQAVDAVAAE LAAEHYHDIK RIAARQNNVA RLWDFLREMV AARRERLLLN LELQKVFQDL
     LYLMDWMAEM KGRLQSQDLG KHLAGVEDLL QLHELVEADI AVQAERVRAV SASALRFCDP
     GKEYRPCDPQ LVSERVATLE QSYEALCELA ATRRARLEES RRLWRFLWEV GEAEAWVREQ
     QHLLASAETG RDLTGVLRLL NKHTALRGEM SGRLGPLKLT LEQGQQLVAE GHPGANQAST
     RAAELQAQWE RLEALAEERA QRLAQAASLY QFQADANDME AWLVDALRLV SSPEVGHDEF
     STQALARQHR ALEEEIRAHR PTLDALREQA AALPPALSHT PEVQGRVPTL EQHYEELQAR
     AGERARALEA ALAFYTMLSE AGACGLWVEE KEQWLNGLAL PERLEDLEVV QQRFETLEPE
     MNALAARVTA VSDIAEQLLK ASPPGKDRII GTQEQLNQRW QQFRSLADGK KAALTSALSI
     QNYHLECTET QAWMREKTKV IESTQDLGND LAGVLALQRK LAGTERDLEA ISARVGELTQ
     EANALAAGHP AQAPAINTRL GEVQTGWEDL RATMRRREES LGEARRLQDF LRSLDDFQAW
     LGRTQTAVAS EEGPATLPEA EALLAQHAAL RGEVERAQSE YSRLRTLGEE VTRDQADPQC
     LFLRQRLEAL GTGWEELGRM WESRQGRLAQ AHGFQGFLRD ARQAEGVLSS QEYFLSHTEM
     PGTLQAADAA IKKLEDFMST MDANGERIRG LLEAGRQLVS KGNIHAEKIQ EKADSIEKRH
     RKNQEAVQQL LGRLRDNREQ QHFLQDCQEL KLWIDEKMLT AQDVSYDEAR NLHTKWQKHQ
     AFMAELAANK DWLDKVDKEG RELTLEKPEL KVLVSEKLED LHRRWDELET TTQAKARSLF
     DANRAELFAQ SCSALESWLE SLQAQLHSDD YGKDLTSVNI LLKKQQMLER EMAVREKEVE
     AIQAQAKALA QEDQSAGEVE RTSRAVEEKF RALCQPMKDR CRRLQASREQ HQFHRDVEDE
     ILWVTERLPM ASSLEHGKDL PSVQLLMKKN QTLQKEIQGH EPRIADLKER QRTLGTAAAG
     PELAELQEMW KRLSHELELR GKRLEEALRA QQFYRDAAEA EAWMGEQELH MMGQEKAKDE
     LSAQAEVKKH QVLEQALADY AQTIKQLAAS SQDMIDHEHP ESTRLTIRQA QVDKLYAGLK
     ELAGERRERL QEHLRLCQLR RELDDLEQWI QEREVVAASH ELGQDYEHVT MLRDKFREFS
     RDTSTIGQER VDSANALANG LIAGGHAARA TVAEWKDSLN EAWADLLELL DTRGQVLAAA
     YELQRFLHGA RQALARVQHK QQQLPDGTGR DLNAAEALQR RHCAYEHDIQ ALSTQVQQVQ
     DDGLRLQKAY AGDKAEEIGR HMQAVAEAWA QLQGSSAARR QLLLDTTDKF RFFKAVRELM
     LWMDGINLQM DAQERPRDVS SADLVIKNQQ GIKAEIEARA DRFSACIDMG QELLARNHYA
     AEEISEKLSQ LQSRRQETAE KWQEKMDWLQ LVLEVLVFGR DAGMAEAWLC SQEPLVRSAE
     LGCTVDEVES LIKRHEAFQK SAVAWEERFS ALEKLTALEE RENEQKRKRE EEERRKQPPT
     SEPMASQPEG SLVDGQRVLD TAWDGTQSKL PPSTQAPSIN GVCTDTESSQ PLLEQQRLEQ
     SNVPEGPGSG TGDESSGPRG ERQTLPRGPA PSPMPQSRSS ESAHVATLPA RGAELSAQEQ
     MEGTLCRKQE MEAFNKKAAN RSWQNVYCVL RRGSLGFYKD ARAASAGVPY HGEVPVSLAR
     AQGSVAFDYR KRKHVFKLGL QDGKEYLFQA KDEAEMSSWL RVVNAAIATA SSASGEPEEP
     VVPSASRGLT RAMTMPPVSQ PEGSIVLRSK DGREREREKR FSFFKKNK
//
